Back
Sangamo Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
SGMO
Sangamo Therapeutics
Last Price:
$2.48
Seasonality Move:
11.45%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SGMO is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sangamo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.31 | Buy |
| 20-day SMA: | 2.17 | Buy |
| 50-day SMA: | 1.94 | Buy |
| 200-day SMA: | 0.98 | Buy |
| 8-day EMA: | 2.35 | Buy |
| 20-day EMA: | 2.21 | Buy |
| 50-day EMA: | 1.93 | Buy |
| 200-day EMA: | 1.25 | Buy |
Sangamo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 58.33 | Buy |
| Chaikin Money Flow: | 9258844 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.88 - 2.38) | Buy |
| Bollinger Bands (100): | (0.73 - 2.07) | Buy |
Sangamo Therapeutics Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sangamo Therapeutics Stock
Is Sangamo Therapeutics Stock a Buy?
-
Sangamo Therapeutics share price is 2.49 while SGMO 8-day simple moving average is 2.31, which is a Buy signal.
-
The stock price of SGMO is 2.49 while Sangamo Therapeutics 20-day SMA is 2.17, which makes it a Buy.
-
Sangamo Therapeutics 50-day simple moving average is 1.94 while SGMO share price is 2.49, making it a Buy technically.
-
SGMO stock price is 2.49 and Sangamo Therapeutics 200-day simple moving average is 0.98, creating a Buy signal.
SGMO Technical Analysis vs Fundamental Analysis
Buy
57
Sangamo Therapeutics (SGMO)
is a Buy
Is Sangamo Therapeutics a Buy or a Sell?
-
Sangamo Therapeutics stock is rated a BuyThe current Sangamo Therapeutics [SGMO] share price is $2.49. The Score for SGMO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Sangamo Therapeutics Stock Info
Market Cap:
518.5M
Price in USD:
2.49
Share Volume:
13.6M
Sangamo Therapeutics 52-Week Range
52-Week High:
3.18
52-Week Low:
0.30
Buy
57
Sangamo Therapeutics (SGMO)
is a Buy
Sangamo Therapeutics Share Price Forecast
-
What is the Sangamo Therapeutics stock price today?The Sangamo Therapeutics stock price is 2.49 USD today.
-
Will SGMO stock go up or go down?Sangamo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sangamo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sangamo Therapeutics is not overvalued.
Is Sangamo Therapeutics Stock a Buy?
-
Sangamo Therapeutics share price is 2.49 while SGMO 8-day exponential moving average is 2.35, which is a Buy signal.
-
The stock price of SGMO is 2.49 while Sangamo Therapeutics 20-day EMA is 2.21, which makes it a Buy.
-
Sangamo Therapeutics 50-day exponential moving average is 1.93 while SGMO share price is 2.49, making it a Buy technically.
-
SGMO stock price is 2.49 and Sangamo Therapeutics 200-day simple moving average is 1.25, creating a Buy signal.
Fundamental Analysis of Sangamo Therapeutics
Is Sangamo Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.32 per share.
Technical Analysis of Sangamo Therapeutics
Should I short Sangamo Therapeutics stock?
-
SGMO Moving Average Covergence Divergence (MACD) indicator is 0.13, suggesting Sangamo Therapeutics is a Buy
-
Sangamo Therapeutics Relative Strength Index (RSI) is 58.33, which suggest Sangamo Therapeutics is overbought
-
The Bollinger Bands (25) for Sangamo Therapeutics is (1.88 - 2.38), which suggest Sangamo Therapeutics is a Buy
-
The Bollinger Bands (100) for Sangamo Therapeutics is (0.73 - 2.07), which suggest Sangamo Therapeutics is a Buy
* Sangamo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.